Abstract
In the present study it was proved first that human recombinant interleukin-6(HrIL-6) significantly augmented natural killer(NK) cell activity derived from human fetal spleens against K562 target cells in a 4 hours51Cr release assay. The enhancement of NK activity with 24 hours preincubation in HrIL-6 was dose-dependent, and significnatly higher than that of fresh NK cells and controls cultured with RPMI-1640 medium alone (P<0.001). We also found that IL-6 was able to augment NK activity from different fetal spleens at 20 to 40 weeks of gestation (up to 2.24 to 2.78 times), and no difference of NK activity of fetal splenocytes treated by HrIL-6 was observed between different fetal age (32.3% to 45.4%,P>0.05). Furthermore, IL-6-augmented NK activity of fetal splenocytes was very similar to adult levels (P>0.05). These finding strongly indicated that IL-6 plays an important role in the development of NK cell function during the gestational period, suggesting that IL-6 may be of importance in the regulation of host defense mechanisms against malignancies and viral diseases.
Similar content being viewed by others
References
Trinchieri G, et al. Response of resting human peripheral blood natural killer cells to IL-2. J Exp Med 1984; 160:1147.
Burns GF, et al. Supernatural killer cells. Immunol Tody 1985; 6:370.
Lopez-Botet M, et al. Functional characterization of human thymocytes: A limiting dilution analysis of precursors with proliferation and cytolytic activities. J Immunol 1985; 134:2299.
Luger TA, et al. IFN-β2/IL-6 augments the activity of human natural killer cells. J Immunol 1989; 143:1206.
Ikebuchi K, et al. Interleukin-6 enhacement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84:9035.
Moore KL. The developing human: Clinically Oriented Embryology. 3rd Edition. Philadelphia: Sanders. 1982; 89, 95.
Uksila J, et al. Natural killer cell function of human neonatal lymphocytes. Clin Exp Immunol 1982; 48:649.
Saito S, et al. Ontogenic development of human natural killer (NK) cell and lymphokine activated killer (LAK) cell. Acta Obst Gynaec Jpn 1987; 39:591.
Mule JJ, et al. Interleukin-4 (B cell stimulatory factor I) can mediated the induction of LAK cell activity directed against fresh tumor cells. J Exp Med 1987; 166:792.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lisheng, L., Zhengyan, C. & Zhigang, T. Regulatory effects of human recombinant IL-6 on natural killer cell activity of human fetal spleens. Chinese Journal of Cancer Research 3, 35–38 (1991). https://doi.org/10.1007/BF02672087
Issue Date:
DOI: https://doi.org/10.1007/BF02672087